Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis

Acta Clin Belg. 2004 Jul-Aug;59(4):223-4. doi: 10.1179/acb.2004.033.

Abstract

Saccharomyces boulardii is widely used as a probiotic compound and is generally thought to be safe. We report one case of fungemia caused by Saccharomyces cerevisiae occurring in an elderly patient treated orally with S. boulardii in association with vancomycin for Clostridium difficile colitis. We do not recommend administering this viable yeast particularly in debilited patient with active colitis.

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Aged
  • Aged, 80 and over
  • Clostridioides difficile / drug effects
  • Clostridioides difficile / isolation & purification*
  • Drug Therapy, Combination
  • Enterocolitis, Pseudomembranous / drug therapy
  • Enterocolitis, Pseudomembranous / microbiology*
  • Female
  • Follow-Up Studies
  • Fungemia / complications
  • Fungemia / diagnosis*
  • Fungemia / drug therapy
  • Humans
  • Probiotics / adverse effects*
  • Risk Assessment
  • Saccharomyces cerevisiae / drug effects
  • Saccharomyces cerevisiae / isolation & purification*
  • Treatment Outcome
  • Vancomycin / therapeutic use
  • Yeast, Dried / therapeutic use

Substances

  • perenterol
  • Vancomycin